Skip to main content

Table 2 Association of miRNA polymorphisms with ACS Risk

From: MiR-146a rs2910164 (G/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort

 

Control (n = 552)

ACS (n = 619)

χ2

OR (95% CI)

P Value

miR146aC > G

 CC

216 (39.13%)

208 (33.60%)

 

1.000 (reference)

 

 CG

263 (47.64%)

302 (48.79%)

1.873(vs. CC)

1.192 (0.927–1.534)

0.171

 GG

73 (13.23%)

109 (17.61%)

5.991 (vs. CC)

1.551 (1.090–2.205)

0.014

Dominant model (CC vs. CG + GG)

3.860

1.270(1.000–1.613)

0.049

Recessive model (CC + CG vs. GG)

4.273

1.402 (1.017–1.934)

0.039

HWE χ2

0.254

0.001

   

HWE p

0.614

0.975

   

miR34bT > C

 TT

245 (44.38%)

291 (47.01%)

 

1.000 (reference)

 

 TC

251 (45.47%)

279 (45.07%)

0.291(vs. TT)

0.936 (0.736 -1.191)

0.589

 CC

56 (10.15%)

49 (7.92%)

2.049(vs. TT)

0.737 (0.484 -1.121)

0.152

Dominant model (TT vs. CT + CC)

 

0.811

0.900 (0.714–1.133)

0.368

Recessive model (TT + CT vs. CC)

 

1.776

0.761(0.509–1.138)

0.183

HWE χ2

0.503

2.543

   

HWE p

0.478

0.111

   
  1. miRNA microRNA; ACS acute coronary syndrome; OR Odds ratio; CI Confidence interval; HWE Hardy–Weinberg equilibrium test